Prevalence of nandrolone preparations with endogenous carbon isotope ratios in Australia

Abstract

AbstractNandrolone and its prohormones, including 19‐norandrost‐4‐ene‐3,17‐dione and 19‐norandrost‐4‐ene‐3β,17β‐diol, are anabolic steroids forbidden at all times in sports according to the World Anti‐Doping Code Prohibited List and its metabolite 19‐norandrosterone (19NA) is the preferred urinary target compound to identify their abuse. In recent years, an increasing number of 19NA isotope ratio mass spectrometry (IRMS) cases have arisen that, based on the initial testing procedure, were likely to result in an adverse analytical finding but were concluded negative after IRMS analysis. The current study was therefore set up to gain a better insight on the prevalence of nandrolone preparations with endogenous carbon isotope ratio values in Australia. Suitable workplace (non‐athlete) urine samples that had previously been reported positive for 19NA were identified and analysed on IRMS. A total of 82% of the samples that were analysed were reported with enriched carbon isotope ratios of 19NA (i.e., 19NA greater than −26‰). This indicates that there is a high prevalence of nandrolone‐containing anabolic androgenic steroid preparations in Australia that have ‘endogenous’ carbon isotope ratios which reduces the ability to identify exogenous nandrolone.